Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35326
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChan, Samantha-
dc.contributor.authorMorgan, Benjamin-
dc.contributor.authorYong, Michelle K-
dc.contributor.authorMargetts, Mai-
dc.contributor.authorFarchione, Anthony J-
dc.contributor.authorLucas, Erin C-
dc.contributor.authorGodsell, Jack-
dc.contributor.authorGiang, Nhi Ai-
dc.contributor.authorSlade, Charlotte A-
dc.contributor.authorvon Borstel, Anouk-
dc.contributor.authorBryant, Vanessa L-
dc.contributor.authorHowson, Lauren J-
dc.date2024-
dc.date.accessioned2024-06-21T06:15:27Z-
dc.date.available2024-06-21T06:15:27Z-
dc.date.issued2024-05-20-
dc.identifier.citationNature Communications 2024-05-20; 15(1)en_US
dc.identifier.issn2041-1723-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35326-
dc.description.abstractThe function and phenotype of γδ T cells in the context of common variable immunodeficiency (CVID) has not been explored. CVID is a primary immunodeficiency disorder characterized by impaired antibody responses resulting in increased susceptibility to infections. γδ T cells are a subset of unconventional T cells that play crucial roles in host defence against infections. In this study, we aim to determine the roles and functions of γδ T cells in CVID. We observe a higher frequency of Vδ1+ γδ T cells compared to healthy controls, particularly in older patients. We also find a higher proportion of effector-memory Vδ1+ γδ T cells and a more clonal T cell receptor (TCR) repertoire in CVID. The most significant driver of the Vδ1+ γδ T cell expansion and phenotype in CVID patients is persistent cytomegalovirus (CMV) viremia. These findings provide valuable insights into γδ T cell biology and their contribution to immune defence in CVID.en_US
dc.language.isoeng-
dc.titleCytomegalovirus drives Vδ1+ γδ T cell expansion and clonality in common variable immunodeficiency.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleNature Communicationsen_US
dc.identifier.affiliationImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.;Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.;Department of Clinical Immunology & Allergy, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationVictorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Immunology & Allergy, Royal Melbourne Hospital, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.;Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.doi10.1038/s41467-024-48527-3en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-3785-7759en_US
dc.identifier.orcid0000-0002-8692-4145en_US
dc.identifier.orcid0000-0003-0615-1515en_US
dc.identifier.orcid0000-0001-5234-0259en_US
dc.identifier.orcid0000-0003-3577-7605en_US
dc.identifier.orcid0000-0001-7909-8714en_US
dc.identifier.orcid0000-0002-3605-7936en_US
dc.identifier.orcid0000-0003-3522-4533en_US
dc.identifier.pubmedid38769332-
dc.description.volume15-
dc.description.issue1-
dc.description.startpage4286-
dc.subject.meshtermssecondaryCommon Variable Immunodeficiency/immunology-
dc.subject.meshtermssecondaryCommon Variable Immunodeficiency/virology-
dc.subject.meshtermssecondaryReceptors, Antigen, T-Cell, gamma-delta/metabolism-
dc.subject.meshtermssecondaryReceptors, Antigen, T-Cell, gamma-delta/immunology-
dc.subject.meshtermssecondaryCytomegalovirus Infections/immunology-
dc.subject.meshtermssecondaryCytomegalovirus Infections/virology-
dc.subject.meshtermssecondaryCytomegalovirus/immunology-
dc.subject.meshtermssecondaryT-Lymphocyte Subsets/immunology-
dc.subject.meshtermssecondaryViremia/immunology-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

58
checked on Feb 17, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.